DKSH Grows its Medical Device Business With the Acquisition of Acutest Systems

DKSH has signed an agreement for the acquisition of Acutest Systems. Founded in the 1980s, Acutest Systems is a distributor of clinical diagnostic point-of-care testing analyzers, diagnostic and screening devices and instruments, and laboratory systems in Malaysia.

The transaction diversifies DKSH’s medical device business and provides the company access to additional general practitioners, pharmacy chains, medical centers, laboratories, and hospitals. Malaysia is a dynamic medical device market which offers significant growth opportunities. Acutest also has a solid customer base and complementary supplier and product portfolios. The company employs around 25 people and recorded net sales of over CHF 3 million in 2021 at sound profitability and returns.

Bijay Singh, Head Business Unit Healthcare at DKSH, commented: “The acquisition of Acutest Systems fits well with our strategy of expanding our medical device business through pragmatic M&A activity. Malaysia has a medical device market that offers growth opportunities. I look forward to welcoming all Acutest employees to DKSH and leveraging on their expertise.”

The closing of the transaction is expected during the second quarter of 2022 and is subject to certain conditions.